vs
Healthpeak Properties（DOC）与TTEC Holdings, Inc.（TTEC）财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是TTEC Holdings, Inc.的1.3倍（$719.4M vs $570.0M），Healthpeak Properties净利率更高（73.2% vs -29.9%，领先103.1%），Healthpeak Properties同比增速更快（3.1% vs 0.4%），Healthpeak Properties自由现金流更多（$357.0M vs $-9.2M），过去两年Healthpeak Properties的营收复合增速更高（8.9% vs -0.6%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
TTEC Holdings, Inc.是一家提供客户体验技术与服务的美国企业，总部运营中心位于得克萨斯州奥斯汀，专注为各行业客户打造全链路客户体验解决方案，凭借专业技术与服务能力深耕全球客户体验服务领域多年。
DOC vs TTEC — 直观对比
营收规模更大
DOC
是对方的1.3倍
$570.0M
营收增速更快
DOC
高出2.6%
0.4%
净利率更高
DOC
高出103.1%
-29.9%
自由现金流更多
DOC
多$366.2M
$-9.2M
两年增速更快
DOC
近两年复合增速
-0.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $719.4M | $570.0M |
| 净利润 | $114.0M | $-170.5M |
| 毛利率 | — | — |
| 营业利润率 | 17.4% | -30.3% |
| 净利率 | 73.2% | -29.9% |
| 营收同比 | 3.1% | 0.4% |
| 净利润同比 | 2406.4% | -3791.9% |
| 每股收益（稀释后） | $0.16 | $-3.57 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCTTEC
| Q4 25 | $719.4M | $570.0M | ||
| Q3 25 | $705.9M | $519.1M | ||
| Q2 25 | $694.3M | $513.6M | ||
| Q1 25 | $702.9M | $534.2M | ||
| Q4 24 | $698.0M | $567.4M | ||
| Q3 24 | $700.4M | $529.4M | ||
| Q2 24 | $695.5M | $534.1M | ||
| Q1 24 | $606.6M | $576.6M |
净利润DOCTTEC
| Q4 25 | $114.0M | $-170.5M | ||
| Q3 25 | $-117.1M | $-13.4M | ||
| Q2 25 | $31.7M | $-8.0M | ||
| Q1 25 | $42.8M | $1.4M | ||
| Q4 24 | $4.5M | $4.6M | ||
| Q3 24 | $85.9M | $-21.1M | ||
| Q2 24 | $146.0M | $-299.5M | ||
| Q1 24 | $6.7M | $-2.3M |
毛利率DOCTTEC
| Q4 25 | — | — | ||
| Q3 25 | 58.6% | — | ||
| Q2 25 | 60.2% | — | ||
| Q1 25 | 61.1% | — | ||
| Q4 24 | 60.3% | — | ||
| Q3 24 | 60.0% | — | ||
| Q2 24 | 60.6% | — | ||
| Q1 24 | 59.8% | — |
营业利润率DOCTTEC
| Q4 25 | 17.4% | -30.3% | ||
| Q3 25 | 9.2% | 2.4% | ||
| Q2 25 | 5.7% | 3.7% | ||
| Q1 25 | 7.7% | 4.5% | ||
| Q4 24 | -2.2% | 2.7% | ||
| Q3 24 | 14.1% | 2.4% | ||
| Q2 24 | 22.3% | -42.0% | ||
| Q1 24 | 3.7% | 3.9% |
净利率DOCTTEC
| Q4 25 | 73.2% | -29.9% | ||
| Q3 25 | -16.6% | -2.6% | ||
| Q2 25 | 4.6% | -1.6% | ||
| Q1 25 | 6.1% | 0.3% | ||
| Q4 24 | 0.7% | 0.8% | ||
| Q3 24 | 12.3% | -4.0% | ||
| Q2 24 | 21.0% | -56.1% | ||
| Q1 24 | 1.1% | -0.4% |
每股收益（稀释后）DOCTTEC
| Q4 25 | $0.16 | $-3.57 | ||
| Q3 25 | $-0.17 | $-0.28 | ||
| Q2 25 | $0.05 | $-0.17 | ||
| Q1 25 | $0.06 | $0.03 | ||
| Q4 24 | $0.02 | $0.05 | ||
| Q3 24 | $0.12 | $-0.44 | ||
| Q2 24 | $0.21 | $-6.30 | ||
| Q1 24 | $0.01 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $467.5M | $82.9M |
| 总债务越低越好 | $9.8B | — |
| 股东权益账面价值 | $7.5B | $112.9M |
| 总资产 | $20.3B | $1.5B |
| 负债/权益比越低杠杆越低 | 1.31× | — |
8季度趋势，按日历期对齐
现金及短期投资DOCTTEC
| Q4 25 | $467.5M | $82.9M | ||
| Q3 25 | $91.0M | $73.5M | ||
| Q2 25 | $89.4M | $82.6M | ||
| Q1 25 | $70.6M | $85.1M | ||
| Q4 24 | $119.8M | $85.0M | ||
| Q3 24 | $180.4M | $96.9M | ||
| Q2 24 | $106.9M | $79.8M | ||
| Q1 24 | $101.8M | $91.5M |
总债务DOCTTEC
| Q4 25 | $9.8B | — | ||
| Q3 25 | $9.1B | — | ||
| Q2 25 | $9.0B | — | ||
| Q1 25 | $8.9B | — | ||
| Q4 24 | $8.7B | — | ||
| Q3 24 | $8.6B | — | ||
| Q2 24 | $8.6B | — | ||
| Q1 24 | $8.8B | — |
股东权益DOCTTEC
| Q4 25 | $7.5B | $112.9M | ||
| Q3 25 | $7.6B | $280.8M | ||
| Q2 25 | $7.9B | $295.2M | ||
| Q1 25 | $8.2B | $281.5M | ||
| Q4 24 | $8.4B | $268.1M | ||
| Q3 24 | $8.6B | $295.1M | ||
| Q2 24 | $8.8B | $304.2M | ||
| Q1 24 | $8.9B | $612.4M |
总资产DOCTTEC
| Q4 25 | $20.3B | $1.5B | ||
| Q3 25 | $19.6B | $1.7B | ||
| Q2 25 | $19.8B | $1.7B | ||
| Q1 25 | $19.8B | $1.7B | ||
| Q4 24 | $19.9B | $1.8B | ||
| Q3 24 | $20.0B | $1.8B | ||
| Q2 24 | $20.2B | $1.8B | ||
| Q1 24 | $20.5B | $2.1B |
负债/权益比DOCTTEC
| Q4 25 | 1.31× | — | ||
| Q3 25 | 1.20× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.04× | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.98× | — | ||
| Q1 24 | 0.99× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | $2.6M |
| 自由现金流经营现金流 - 资本支出 | $357.0M | $-9.2M |
| 自由现金流率自由现金流/营收 | 49.6% | -1.6% |
| 资本支出强度资本支出/营收 | 124.4% | 2.1% |
| 现金转化率经营现金流/净利润 | 10.99× | — |
| 过去12个月自由现金流最近4个季度 | — | $83.0M |
8季度趋势，按日历期对齐
经营现金流DOCTTEC
| Q4 25 | $1.3B | $2.6M | ||
| Q3 25 | $315.0M | $4.2M | ||
| Q2 25 | $363.5M | $92.7M | ||
| Q1 25 | $279.4M | $21.6M | ||
| Q4 24 | $1.1B | $-1.1M | ||
| Q3 24 | $318.2M | $-91.4M | ||
| Q2 24 | $316.2M | $49.3M | ||
| Q1 24 | $152.6M | $-15.6M |
自由现金流DOCTTEC
| Q4 25 | $357.0M | $-9.2M | ||
| Q3 25 | — | $-9.6M | ||
| Q2 25 | — | $85.5M | ||
| Q1 25 | — | $16.2M | ||
| Q4 24 | $333.7M | $-9.8M | ||
| Q3 24 | — | $-100.2M | ||
| Q2 24 | — | $35.1M | ||
| Q1 24 | — | $-29.1M |
自由现金流率DOCTTEC
| Q4 25 | 49.6% | -1.6% | ||
| Q3 25 | — | -1.8% | ||
| Q2 25 | — | 16.7% | ||
| Q1 25 | — | 3.0% | ||
| Q4 24 | 47.8% | -1.7% | ||
| Q3 24 | — | -18.9% | ||
| Q2 24 | — | 6.6% | ||
| Q1 24 | — | -5.0% |
资本支出强度DOCTTEC
| Q4 25 | 124.4% | 2.1% | ||
| Q3 25 | — | 2.7% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | 105.6% | 1.5% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 2.7% | ||
| Q1 24 | — | 2.3% |
现金转化率DOCTTEC
| Q4 25 | 10.99× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 11.48× | — | ||
| Q1 25 | 6.52× | 15.60× | ||
| Q4 24 | 235.43× | -0.24× | ||
| Q3 24 | 3.71× | — | ||
| Q2 24 | 2.17× | — | ||
| Q1 24 | 22.85× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
暂无分部数据
TTEC
| Ttec Engage | $444.5M | 78% |
| Ttec Digital | $125.5M | 22% |
